| Bioactivity | (R)-Elsubrutinib ((R)-ABBV-105) is a Btk inhibitor. (R)-Elsubrutinib can be used in studies of immune diseases (such as rheumatoid arthritis, psoriasis, ankylosing spondylitis, asthma, systemic lupus erythematosus) and cancer[1]. | ||||||||||||
| Name | (R)-Elsubrutinib | ||||||||||||
| CAS | 1643570-23-3 | ||||||||||||
| Formula | C17H19N3O2 | ||||||||||||
| Molar Mass | 297.35 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Dominique Bonafoux, et al. Primary carboxamides as Btk inhibitors. Patent WO2014210255Al. |
(R)-Elsubrutinib
CAS: 1643570-23-3 F: C17H19N3O2 W: 297.35
(R)-Elsubrutinib ((R)-ABBV-105) is a Btk inhibitor. (R)-Elsubrutinib can be used in studies of immune diseases (such as
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.